Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Diabetes

  Free Subscription


Articles published in Hypertension

Retrieve available abstracts of 27 articles:
HTML format
Text format



Single Articles


    July 2018
  1. TSUJIMOTO T, Kajio H
    Benefits of Intensive Blood Pressure Treatment in Patients With Type 2 Diabetes Mellitus Receiving Standard but Not Intensive Glycemic Control.
    Hypertension. 2018 Jul 2. pii: HYPERTENSIONAHA.118.11408.
    PubMed     Text format     Abstract available


  2. KJELDSEN SE, Os I, Nilsson PM
    Does Intensive Glucose Control Cancel Out Benefits of Systolic Blood Pressure Target <120 mm Hg in Patients With Diabetes Mellitus Participating in ACCORD?
    Hypertension. 2018 Jul 2. pii: HYPERTENSIONAHA.118.11455.
    PubMed     Text format    


    June 2018
  3. SHIN D, Bohra C, Kongpakpaisarn K
    Impact of the Discordance Between the American College of Cardiology/American Heart Association and American Diabetes Association Recommendations on Hypertension in Patients With Diabetes Mellitus in the United States.
    Hypertension. 2018 Jun 25. pii: HYPERTENSIONAHA.118.11422.
    PubMed     Text format    


  4. TONNEIJCK L, Muskiet MHA, Twisk JW, Kramer MHH, et al
    Lixisenatide Versus Insulin Glulisine on Fasting and Postbreakfast Systemic Hemodynamics in Type 2 Diabetes Mellitus Patients.
    Hypertension. 2018 Jun 18. pii: HYPERTENSIONAHA.117.10740.
    PubMed     Text format     Abstract available


    April 2018
  5. GOLIC M, Stojanovska V, Bendix I, Wehner A, et al
    Diabetes Mellitus in Pregnancy Leads to Growth Restriction and Epigenetic Modification of the Srebf2 Gene in Rat Fetuses.
    Hypertension. 2018 Apr 2. pii: HYPERTENSIONAHA.117.10782.
    PubMed     Text format     Abstract available


  6. SCIOSCIA M
    Relevant Fetal Epigenetic Modifications Result From a Diabetic Intrauterine Environment: Healthy Aging Starts With a Healthy Pregnancy.
    Hypertension. 2018 Apr 2. pii: HYPERTENSIONAHA.118.10868.
    PubMed     Text format    


    March 2018
  7. AGGARWAL R, Steinkamp J, Chiu N, Petrie B, et al
    Intensive Blood Pressure Targets for Diabetic and Other High-Risk Populations: A Pooled Individual Patient Data Analysis.
    Hypertension. 2018 Mar 12. pii: HYPERTENSIONAHA.117.10713.
    PubMed     Text format     Abstract available


    January 2018
  8. TSIMIHODIMOS V, Gonzalez-Villalpando C, Meigs JB, Ferrannini E, et al
    Hypertension and Diabetes Mellitus: Coprediction and Time Trajectories.
    Hypertension. 2018 Jan 15. pii: HYPERTENSIONAHA.117.10546.
    PubMed     Text format     Abstract available


    October 2017
  9. WAN EYF, Yu EYT, Fung CSC, Chin WY, et al
    Do We Need a Patient-Centered Target for Systolic Blood Pressure in Hypertensive Patients With Type 2 Diabetes Mellitus?
    Hypertension. 2017 Oct 16. pii: HYPERTENSIONAHA.117.10034.
    PubMed     Text format     Abstract available


    August 2017
  10. SAVOIA C, Touyz RM
    Hypertension, Diabetes Mellitus, and Excess Cardiovascular Risk Importance of Baseline Systolic Blood Pressure.
    Hypertension. 2017 Aug 28. pii: HYPERTENSIONAHA.117.09764.
    PubMed     Text format    


  11. NAVAR AM, Gallup DS, Lokhnygina Y, Green JB, et al
    Hypertension Control in Adults With Diabetes Mellitus and Recurrent Cardiovascular Events: Global Results From the Trial Evaluating Cardiovascular Outcomes With Sitagliptin.
    Hypertension. 2017 Aug 28. pii: HYPERTENSIONAHA.117.09482.
    PubMed     Text format     Abstract available


    June 2017
  12. OHKUMA T, Woodward M, Jun M, Muntner P, et al
    Prognostic Value of Variability in Systolic Blood Pressure Related to Vascular Events and Premature Death in Type 2 Diabetes Mellitus: The ADVANCE-ON Study.
    Hypertension. 2017 Jun 5. pii: HYPERTENSIONAHA.117.09359.
    PubMed     Text format     Abstract available


    May 2017
  13. TSUJIMOTO T, Sugiyama T, Shapiro MF, Noda M, et al
    Risk of Cardiovascular Events in Patients With Diabetes Mellitus on beta-Blockers.
    Hypertension. 2017 May 30. pii: HYPERTENSIONAHA.117.09259.
    PubMed     Text format     Abstract available


  14. CASIGLIA E, Tikhonoff V
    Long-Standing Problem of beta-Blocker-Elicited Hypoglycemia in Diabetes Mellitus.
    Hypertension. 2017 May 30. pii: HYPERTENSIONAHA.117.09378.
    PubMed     Text format    


    April 2017
  15. SAFAR ME, Gnakamene JB, Bahous SA, Yannoutsos A, et al
    Longitudinal Study of Hypertensive Subjects With Type 2 Diabetes Mellitus: Overall and Cardiovascular Risk.
    Hypertension. 2017 Apr 10. pii: HYPERTENSIONAHA.116.08962.
    PubMed     Text format     Abstract available


  16. STARUSCHENKO A
    Hypertension and Diabetes Mellitus: The Chicken and Egg Problem.
    Hypertension. 2017 Apr 3. pii: HYPERTENSIONAHA.117.08671.
    PubMed     Text format    


  17. LEE H, Dominiczak AF, Jennings GL, Cho EJ, et al
    Case of Chronic Indolent Pheochromocytoma That Caused Medically Controlled Hypertension but Treatment-Resistant Diabetes Mellitus.
    Hypertension. 2017 Apr 3. pii: HYPERTENSIONAHA.117.09183.
    PubMed     Text format    


    March 2017
  18. WANG Z, do Carmo JM, Aberdein N, Zhou X, et al
    Synergistic Interaction of Hypertension and Diabetes in Promoting Kidney Injury and the Role of Endoplasmic Reticulum Stress.
    Hypertension. 2017 Mar 27. pii: HYPERTENSIONAHA.116.08560.
    PubMed     Text format     Abstract available


    December 2016
  19. MANCIA G, Cannon CP, Tikkanen I, Zeller C, et al
    Impact of Empagliflozin on Blood Pressure in Patients With Type 2 Diabetes Mellitus and Hypertension by Background Antihypertensive Medication.
    Hypertension. 2016;68:1355-1364.
    PubMed     Text format     Abstract available


    August 2016
  20. ALVES-LOPES R, Neves KB, Montezano AC, Harvey A, et al
    Internal Pudental Artery Dysfunction in Diabetes Mellitus Is Mediated by NOX1-Derived ROS-, Nrf2-, and Rho Kinase-Dependent Mechanisms.
    Hypertension. 2016 Aug 15. pii: HYPERTENSIONAHA.116.07518.
    PubMed     Text format     Abstract available


  21. FLEG JL, Evans GW, Margolis KL, Barzilay J, et al
    Orthostatic Hypotension in the ACCORD (Action to Control Cardiovascular Risk in Diabetes) Blood Pressure Trial: Prevalence, Incidence, and Prognostic Significance.
    Hypertension. 2016 Aug 8. pii: HYPERTENSIONAHA.116.07474.
    PubMed     Text format     Abstract available


  22. ARONOW WS
    Orthostatic Hypotension in Diabetics in the ACCORD (Action to Control Cardiovascular Risk in Diabetes) Blood Pressure Trial.
    Hypertension. 2016 Aug 8. pii: HYPERTENSIONAHA.116.07605.
    PubMed     Text format    


  23. WHITE WB, Wilson CA, Bakris GL, Bergenstal RM, et al
    Angiotensin-Converting Enzyme Inhibitor Use and Major Cardiovascular Outcomes in Type 2 Diabetes Mellitus Treated With the Dipeptidyl Peptidase 4 Inhibitor Alogliptin.
    Hypertension. 2016 Aug 1. pii: HYPERTENSIONAHA.116.07797.
    PubMed     Text format     Abstract available


    June 2016
  24. RYAN MJ
    "Slow"ing Cardiovascular Risk in Type 2 Diabetics by Restricting Dietary Salt Intake.
    Hypertension. 2016;67:1124-5.
    PubMed     Text format    


  25. SUCKLING RJ, He FJ, Markandu ND, MacGregor GA, et al
    Modest Salt Reduction Lowers Blood Pressure and Albumin Excretion in Impaired Glucose Tolerance and Type 2 Diabetes Mellitus: A Randomized Double-Blind Trial.
    Hypertension. 2016;67:1189-95.
    PubMed     Text format     Abstract available


    May 2016
  26. WU Z, Jin C, Vaidya A, Jin W, et al
    Longitudinal Patterns of Blood Pressure, Incident Cardiovascular Events, and All-Cause Mortality in Normotensive Diabetic People.
    Hypertension. 2016 May 23. pii: HYPERTENSIONAHA.116.07381.
    PubMed     Text format     Abstract available


  27. WHALEY-CONNELL A, Sowers JR
    Blood Pressure-Related Outcomes in a Diabetic Population.
    Hypertension. 2016 May 23. pii: HYPERTENSIONAHA.116.07439.
    PubMed     Text format    


Thank you for your interest in scientific medicine.


AMEDEO Diabetes is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: